Life Science Newsletter: Bats weigh in on driverless cars, Covid-19’s impact on our values, NIH on lazy eye...

Redington Life Sciences News

Special Issue October 2021

In this issue: Bats weigh in on driverless cars, Covid-19’s impact on our values, NIH on lazy eye, Mayo’s new ideas for breast cancer prevention, antibiotics and stunted growth, brain scans time dementia’s onset, opioids and IBD, gut bugs drive prostate cancer, Dana Farber on mast cell precursors, new model to study Down syndrome, and more…


Can bats help us design a better driverless car?

Bakar Fellow Michael Yartsev is translating bats’ neurological 'rules of the road' into computational algorithms to guide development of navigation systems for driverless cars.

Full Details


Study provides more evidence of how COVID-19 changed Americans’ values, activities

A UCLA-led survey bolsters findings of an earlier analysis of online behavior during the pandemic.

Full Details


NIH-funded study shows screening device accurately detects amblyopia (lazy eye) 

Early detection is key to treating condition that can affect children’s success in school and lifelong visual acuity.


Mayo Clinic researchers advocate new approach to breast cancer prevention

A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to modify breast cancer risk and potentially reduce breast cancer incidence and mortality. "

Full Details



Stem cell project to create new model to study brain development and Down syndrome

With an $11 million Transformative Research grant from the National Institutes of Health, University of Wisconsin–Madison Waisman Center researchers are creating a new approach to study how changes to brain development in the womb result in intellectual disability in people with Down syndrome. 

Full Details


Antibiotics Alone Can’t Protect Kids From Stunted Growth 

New findings suggest antibiotics alone won't end the cycle of stunted growth and poverty that afflicts children across the developing world.

Full Details


Diving deeper to measure the toll of ‘ice’ on mental health 

A new study indicates methamphetamine smokers are likely to experience higher levels of depression and anxiety than the general population.

Full Details


'Gut bugs' can drive prostate cancer growth and treatment resistance 

Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.

Full Details


Johns Hopkins researchers find thousands of unknown chemicals in electronic cigarettes

Study identifies compounds undisclosed by popular brands including industrial chemicals, caffeine


Allergic stimulation activates mast cell precursor cells

Mast cell precursor cells do not just cause an increase in mature mast cells during inflammation, they also play an active role in diseases like asthma, according to a new study.

Full Details


Time until dementia symptoms appear can be estimated via brain scan 

Researchers at Washington University School of Medicine in St. Louis have developed an approach to estimating when a person who is likely to develop Alzheimer’s disease, but has no cognitive symptoms, will start showing signs of Alzheimer’s dementia.

Full Details


Staying on long-term antidepressants reduces risk of relapse study suggests

When people stop taking antidepressants after a long period of use, just over half (56%) experience a relapse within a year, compared to 39% of those who stay on medication, finds a new study led by UCL and including researchers from the University of Southampton.


New study suggests that aquaporin could be key to repairing corneal defects 

Corneal defects often heal themselves, but serious injuries that are left untreated can result in inflammation, infection, ulceration and even blindness. A new study provides exciting evidence supporting the involvement of aquaporins in corneal cell proliferation and nerve regeneration and suggests aquaporin 5 (AQP5) induction as a potential therapy to accelerate the resurfacing of corneal defects...

Full Details


New treatment for inflammatory bowel disease: Opioids may cure that 'bad gut feeling' 

Opioid receptors play key roles in regulating our senses and emotions. Recently, their discovery outside the nervous system raised several questions about the effects of opioids on the immune system. Now, researchers have shown that KNT-127 -- a drug that targets delta opioid receptors...

Full Details

Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs

Available, FDA-approved drugs may be effective in targeting about 80% of never-smokers’ lung tumors

Full Details


Gut microbe signatures may indicate adverse reaction to cancer treatments

A collaborative study involving Monash University has revealed specific gut microbiota signatures that may signal adverse body responses to cancer immunotherapy treatments.


NIAID Scientists Find a Key to Hepatitis C Entry into Cells 

Understanding Structure of HCV Proteins Could Aid in Vaccine Development.

Full Details


Scientists use AI to identify new drug combination for children with incurable brain cancer 

Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer.

Full Details


Cancer Cells’ Unexpected Genetic Tricks for Evading the Immune System 

In a surprising new finding in mice, researchers have discovered that many genes linked to human cancer block the body’s natural defense against malignancies.



UCLA research reveals how a year of change affected Californians’ health 

The latest California Health Interview Survey quantifies the impact of pandemic, racial tensions and other challenges.



Omega-3 Supplements May Slow Memory Decline

Six months of daily supplements of omega-3 increased the levels of two biomarkers of inflammation and nerve damage in the cerebrospinal fluid (CSF) of people with Alzheimer’s disease , according to a post-hoc analysis of data from the OmegAD clinical trial.

Full Details

Ph: 212 926-1733     Email: